Completed PHASE3 INTERVENTIONAL 2-arm NCT01436994

Antithyroid Drug Treatment of Thyrotoxicosis in Young People

A Randomised Study of Two Anti-thyroid Drug Treatment Regimens in Young People

Sponsor: Newcastle-upon-Tyne Hospitals NHS Trust

Interventions Block and Replace Dose Titration carbimazole propylthiouracil thyroxine

Updated 5 times since 2017 Last updated: Sep 20, 2016 Started: Jul 31, 2004 Primary completion: Dec 31, 2014 Completion: Nov 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Paediatric Thyrotoxicosis and is currently completed. Newcastle-upon-Tyne Hospitals NHS Trust leads this study, which shows 5 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jul 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Newcastle-upon-Tyne Hospitals NHS Trust

Data source: Newcastle-upon-Tyne Hospitals NHS Trust

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aberdeen, United Kingdom , Birmingham, United Kingdom , Cambridge, United Kingdom , Cardiff, United Kingdom , Coventry, United Kingdom , Dundee, United Kingdom , Edinburgh, United Kingdom , Glasgow, United Kingdom , Hereford, United Kingdom , Kilmarnock, United Kingdom and 7 more locations